HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer
Non-small cell lung cancer (NSCLC) ranks the first in incidence and mortality among malignant tumors in China. Molecular targeted therapies such as gefitinib, an oral inhibitor of the epidermal growth factor receptor tyrosine kinase, have shown significant benefits in patients with advanced NSCLC. H...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
China Science Publishing & Media Ltd.
2022-04-01
|
| Series: | Acta Biochimica et Biophysica Sinica |
| Subjects: | |
| Online Access: | https://www.sciengine.com/doi/10.3724/abbs.2022023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850271403861868544 |
|---|---|
| author | Lei Tianyao Huang Jiali Xie Fei Gu Jingyao Cheng Zhixiang Wang Zhaoxia |
| author_facet | Lei Tianyao Huang Jiali Xie Fei Gu Jingyao Cheng Zhixiang Wang Zhaoxia |
| author_sort | Lei Tianyao |
| collection | DOAJ |
| description | Non-small cell lung cancer (NSCLC) ranks the first in incidence and mortality among malignant tumors in China. Molecular targeted therapies such as gefitinib, an oral inhibitor of the epidermal growth factor receptor tyrosine kinase, have shown significant benefits in patients with advanced NSCLC. However, most patients have unsatisfactory outcomes due to the development of drug resistance, and there is an urgent need to better understand the pathways involved in the resistance mechanisms. In this study, we found that HMGB1 is highly expressed in drug-resistant cells and confers to gefitinib resistance in NSCLC cells via activating autophagy process. Gefitinib upregulates HMGB1 expression in time-dependent and dose-dependent manners in human NSCLC cells. RNA interference-mediated knockdown of HMGB1 reduces PC9GR cell viability, induces apoptosis, and partially restores gefitinib sensitivity. Mechanistic analyses indicate that elevated HMGB1 expression contributes to gefitinib resistance by inducing autophagy. Thus, our results suggest that HMGB1 is an autophagy regulator and plays a key role in gefitinib resistance of NSCLC. |
| format | Article |
| id | doaj-art-c7929abfadca473592200b69e32b7d96 |
| institution | OA Journals |
| issn | 1672-9145 |
| language | English |
| publishDate | 2022-04-01 |
| publisher | China Science Publishing & Media Ltd. |
| record_format | Article |
| series | Acta Biochimica et Biophysica Sinica |
| spelling | doaj-art-c7929abfadca473592200b69e32b7d962025-08-20T01:52:15ZengChina Science Publishing & Media Ltd.Acta Biochimica et Biophysica Sinica1672-91452022-04-015451452310.3724/abbs.202202320d259ccHMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancerLei Tianyao0Huang Jiali1Xie Fei2Gu Jingyao3Cheng Zhixiang4Wang Zhaoxia5[][][][][][]Non-small cell lung cancer (NSCLC) ranks the first in incidence and mortality among malignant tumors in China. Molecular targeted therapies such as gefitinib, an oral inhibitor of the epidermal growth factor receptor tyrosine kinase, have shown significant benefits in patients with advanced NSCLC. However, most patients have unsatisfactory outcomes due to the development of drug resistance, and there is an urgent need to better understand the pathways involved in the resistance mechanisms. In this study, we found that HMGB1 is highly expressed in drug-resistant cells and confers to gefitinib resistance in NSCLC cells via activating autophagy process. Gefitinib upregulates HMGB1 expression in time-dependent and dose-dependent manners in human NSCLC cells. RNA interference-mediated knockdown of HMGB1 reduces PC9GR cell viability, induces apoptosis, and partially restores gefitinib sensitivity. Mechanistic analyses indicate that elevated HMGB1 expression contributes to gefitinib resistance by inducing autophagy. Thus, our results suggest that HMGB1 is an autophagy regulator and plays a key role in gefitinib resistance of NSCLC.https://www.sciengine.com/doi/10.3724/abbs.2022023gefitinib resistancehigh-mobility group box 1autophagynon-small cell lung cancer |
| spellingShingle | Lei Tianyao Huang Jiali Xie Fei Gu Jingyao Cheng Zhixiang Wang Zhaoxia HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer Acta Biochimica et Biophysica Sinica gefitinib resistance high-mobility group box 1 autophagy non-small cell lung cancer |
| title | HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer |
| title_full | HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer |
| title_fullStr | HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer |
| title_full_unstemmed | HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer |
| title_short | HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer |
| title_sort | hmgb1 mediated autophagy promotes gefitinib resistance in human non small cell lung cancer |
| topic | gefitinib resistance high-mobility group box 1 autophagy non-small cell lung cancer |
| url | https://www.sciengine.com/doi/10.3724/abbs.2022023 |
| work_keys_str_mv | AT leitianyao hmgb1mediatedautophagypromotesgefitinibresistanceinhumannonsmallcelllungcancer AT huangjiali hmgb1mediatedautophagypromotesgefitinibresistanceinhumannonsmallcelllungcancer AT xiefei hmgb1mediatedautophagypromotesgefitinibresistanceinhumannonsmallcelllungcancer AT gujingyao hmgb1mediatedautophagypromotesgefitinibresistanceinhumannonsmallcelllungcancer AT chengzhixiang hmgb1mediatedautophagypromotesgefitinibresistanceinhumannonsmallcelllungcancer AT wangzhaoxia hmgb1mediatedautophagypromotesgefitinibresistanceinhumannonsmallcelllungcancer |